Laboratoire Français du Fractionnement et des Biotechnologies has 3,936 employees, according to Revelio Labs workforce intelligence data. The YoY growth rate is 6.5%.
Data source: Revelio Labs Coverage: Global workforce Latest update: September 2025
LFB is a biopharmaceutical group that develops, manufactures and markets medicinal products for the treatment of serious and often rare diseases in several major therapeutic fields, namely Hemostasis, Immunology and Intensive Care. With most of its products indicated for serious and rare diseases, LFB is a major player in this area. The LFB Group is the leading manufacturer of plasma-derived medicinal products in France and 5th worldwide and is also among the leading European companies for the development of new-generation proteins and treatments based on biotechnologies. With a sustained investment in research and development, the LFB Group bases its strategy on its international deployment and the design of innovative therapies.
As of September 2025
Laboratoire Francais
workforce metrics
Headcount
3.9k
Avg. Salary
$54.7k
Tenure
4.8yr
Growth Rate
6.5%
Hiring Rate
Attrition Rate
For even more metrics data,
reach out to our sales team.
Interactive chart of Laboratoire Francais annual worldwide employee count from 2023 to 2025.
Would you like to see the latest employee headcount data?
Would you like to see the latest employee geographic data?
Interactive chart of Laboratoire Francais annual active job postings from 2023 to 2025.
Would you like to see the latest active job postings data?
Sentiment Topics
Would you like to see the latest employee sentiment data?